{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib3q4dkswwjnfs2awwizyth7aauehcw6irqpu4ljllys7f3jllo7u",
    "uri": "at://did:plc:4zlmjfmdbxj3qhzh3qrwdw6u/app.bsky.feed.post/3mgfeq7lex2q2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig7gi32gaufzirznelt4hgecex4lom22badd3cpmho6juoo5k2xim"
    },
    "mimeType": "image/jpeg",
    "size": 210704
  },
  "path": "/culture/annals-of-inquiry/can-a-living-drug-cure-autoimmune-diseases",
  "publishedAt": "2026-03-06T11:00:00.000Z",
  "site": "https://www.newyorker.com",
  "tags": [
    "Culture / Annals of Inquiry",
    "Science / Annals of Medicine",
    "Multiple Sclerosis",
    "Diseases",
    "Treatment"
  ],
  "textContent": "CAR-T was developed as a cancer treatment. Now it is showing promise for conditions that have long been considered incurable, such as lupus and multiple sclerosis.",
  "title": "Can a “Living Drug” Cure Autoimmune Diseases?"
}